Auris Medical Reaches Midpoint for Enrollment in AM-201 Phase 1b Proof-of-Concept Study in Antipsychotic-Induced Weight Gain

NEXT STORY
Sanofi : Dupixent® (dupilumab) Approved for Severe Asthma by European Commission
PREV STORY
Akcea and Ionis Announce Approval of WAYLIVRA® (volanesorsen) in the European Union
Subscribe now to PM360
Get in touch with PM360 Experts On Call

Experts on Call

Ads

You May Also Like

Orgenesis Announces Planned Study to Confirm Suitability of Liver Cells as a Source for Personalized Cell Replacement Therapy for Insulin-Dependent Diabetic Patients

author_avatar
NASDAQ Market News

The global generic drugs market size to $786.0 billion by 2030 from $278.4 billion in 2019, at a 10.0% CAGR between 2020 and 2030

author_avatar
NASDAQ Market News

Handtevy Pediatric Emergency Care Course Helping EMS Improve Care for Sick and Injured Children in the Field

FORT LAUDERDALE, FL--(Marketwired - March 09, 2017) - Handtevy - Pediatric Emergency Standards, Inc. ...

author_avatar
NASDAQ Market News